A phase 1 dose escalation study of BI 831266, an inhibitor of Aurora kinase B, in patients with advanced solid tumors

por Dittrich, Christian, Fridrik, Michael A., Koenigsberg, Robert, Lee, Chooi, Goeldner, Rainer-Georg, Hilbert, James, Greil, Richard
Publicado 2014